David Angulo
2019
In 2019, David Angulo earned a total compensation of $1M as Chief Medical Officer at SCYNEXIS, a 32% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $201,990 |
|---|---|
| Option Awards | $127,980 |
| Salary | $436,967 |
| Stock Awards | $207,000 |
| Other | $37,169 |
| Total | $1,011,106 |
Angulo received $437K in salary, accounting for 43% of the total pay in 2019.
Angulo also received $202K in non-equity incentive plan, $128K in option awards, $207K in stock awards and $37.2K in other compensation.
Rankings
In 2019, David Angulo's compensation ranked 9,211th out of 13,971 executives tracked by ExecPay. In other words, Angulo earned more than 34.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,211 out of 13,971 | 34th |
Division Manufacturing | 3,689 out of 5,698 | 35th |
Major group Chemicals And Allied Products | 1,400 out of 2,197 | 36th |
Industry group Drugs | 1,193 out of 1,883 | 37th |
Industry Pharmaceutical Preparations | 886 out of 1,395 | 37th |
Source: SEC filing on May 29, 2020.
Angulo's colleagues
We found two more compensation records of executives who worked with David Angulo at SCYNEXIS in 2019.
News
SCYNEXIS CEO David Angulo's 2023 pay rises 4% to $1.2M
April 25, 2024
SCYNEXIS CEO Marco Taglietti's 2022 pay jumps 52% to $2.6M
May 1, 2023
SCYNEXIS CEO Marco Taglietti's 2021 pay rises 18% to $1.7M
May 12, 2022
SCYNEXIS CEO Marco Taglietti's 2020 pay slips 6% to $1.4M
April 26, 2021
SCYNEXIS CEO Marco Taglietti's 2019 pay jumps 38% to $1.5M
May 29, 2020
SCYNEXIS CEO Marco Taglietti's 2018 pay slips 9% to $1.1M
May 7, 2019